Anchyra Partners’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
Other funds holding TAK
Anchyra Partners's TAK Position: Q3 2026 in Review
Anchyra Partners opened a new position in Takeda Pharmaceutical (TAK) in Q3 2026: 12,160 shares worth $221K. The stake represents 0.05% of the portfolio and ranks #353 among its holdings. This is a return to the name: Anchyra Partners previously reported a position in TAK as recently as Q1 2026.
Anchyra Partners first reported a position in TAK in Q1 2026 and has held it in 2 quarters since. The position peaked at $231K in Q1 2026. 396 funds tracked by Wall St. Rank hold TAK as of Q3 2026.
- Anchyra Partners held 12,160 shares of Takeda Pharmaceutical worth $221K as of Q3 2026.
- Takeda Pharmaceutical was a new Anchyra Partners position in Q3 2026.
- Takeda Pharmaceutical made up 0.05% of Anchyra Partners's portfolio in Q3 2026, its #353 holding.
- Anchyra Partners first reported a position in Takeda Pharmaceutical in Q1 2026 and has held it in 2 quarters since.
- Anchyra Partners's Takeda Pharmaceutical position peaked at $231K in Q1 2026.
- 396 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2026.
Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.